VanEck Biotech ETF
BBH
BBH
79 hedge funds and large institutions have $211M invested in VanEck Biotech ETF in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-7
Holders Change %
-8.14%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
23
Reduced
25
Closed
14
Calls
$3.8M
Puts
$1.07M
Net Calls
+$2.73M
Net Calls Change
+$11.1M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$28.8M |
| 2 |
VF
Virtu Financial
New York
|
+$6.06M |
| 3 |
MLL
Moody Lynn & Lieberson
Boston,
Massachusetts
|
+$4.65M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.08M |
| 5 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
+$1.81M |
Top Sellers
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
-$4.79M |
| 2 |
SG Americas Securities
New York
|
-$2.63M |
| 3 |
AL
Aspiriant LLC
Los Angeles,
California
|
-$2.5M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.74M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.72M |
